Search results

Page results

• Towards sustainable clinical activity

  Delivering vital interventions, medicines and all other healthcare services are responsible for a major part of the NHS’s carbon emissions. We need to redesign our services to reduce their environmental impact, whilst maintaining the highest standards of care delivery. This page outlines our progress so far.

• Towards sustainable estates, facilities, technology and transport

  As an organisation, UCLH needs to minimise the environmental impact of our buildings and the energy they use and maximise our use of any technology available to support these changes. This page outlines our progress to date.

• MENO.pause app launched to help clinicians manage patients’ menopause symptoms

  Doctors at UCLH and University College London (UCL) have developed a digital decision-making aid, MENO.pause, to help clinicians manage menopause symptoms in the best way for individual patients’ health conditions.

• UCLH top trust to work at in England

  Our staff have rated UCLH as the top trust in England, improving on our ranking from last year when we were third best in England and top in London.

• UCLH and Whittington children’s dental service scoops award

  A UCLH and Whittington Health children’s dental service has won the Small Scale, Big Impact award at the Smarter Working Live awards for its work supporting community dentists to provide more dental treatment locally, saving trips to hospital.

• Research autopsies reveal how incurable skin cancer resists treatment

  Research conducted at UCLH has discovered how some skin cancers stop responding to treatment at the end of life.

• In focus: cancer research using proton beam therapy

  More than 400 patients at UCLH have so far benefited from an exciting new cancer treatment called proton beam therapy (PBT) – which uses high-energy beams of protons, rather than X-rays, to deliver a dose of radiotherapy.

• National play toolkit to reduce children’s medical trauma launched at UCLH

  A new toolkit to support babies, children and young people in healthcare access high quality health play services was launched at UCLH last week with UCLH chief nurse Vanessa Sweeney welcoming visitors from NHS England and the play charity Starlight.

• Immunomodulatory drug for COVID-19 trialled at UCLH

  UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).

• First treatment for rare disease approved by UK medicines regulator

  The first ever treatment for the rare neurodegenerative disease Friedreich’s ataxia – for which UCLH and UCL led the UK trial – has been approved for use in the UK by the medicines’ regulator.